DrugDashboards

Hydroxyzine Hydrochloride

hydroxyzine hydrochloride · HYDROXYZINE DIHYDROCHLORIDE 10 mg/1 · Tablet, Film Coated · Oral · KVK-Tech, Inc.

NDC 10702-0010-01 · 100 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

19 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0286 per unit over the past year. One of its named manufacturing plants, Kvk-Tech, Inc., failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0286per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.0286per TABweighted avg manufacturer price $0.0122 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1$0.15Nov 2013Sep 2026$0.0286
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$0.86
#90 count
$2.57

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$51,220
5,521 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for hydroxyzine hydrochloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA040786
TE code
AB
Approval date
Mar 20, 2007
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedDec 11, 2013
    KVK-Tech, Inc. — Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.
  • Class II · TerminatedDec 11, 2013
    KVK-Tech, Inc. — Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.
  • Class II · TerminatedDec 11, 2013
    KVK-Tech, Inc. — Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Manufacturers of hydroxyzine hydrochloride (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 3, 2026
Proficient Rx LPHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 3, 2026
Remedyrepack Inc.HYDROXYZINE HYDROCHLORIDE 25 mg/1Jul 24, 2026Sep 3, 2026
A-S Medication SolutionsHYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx of Tennessee, LLCHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx of Tennessee, LLCHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Advanced Rx Pharmacy of Tennessee, LLCHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingHYDROXYZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingHYDROXYZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackHYDROXYZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackHYDROXYZINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCHYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCHYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Epic Pharma, LLCHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.HYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.HYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
KVK-Tech, Inc.HYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsHYDROXYZINE HYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsHYDROXYZINE HYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
Marlex Pharmaceuticals, Inc.HYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026
Northwind Health Company, LLCHYDROXYZINE DIHYDROCHLORIDE 50 mg/1Jul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, IncHYDROXYZINE DIHYDROCHLORIDE 25 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Hydroxyzine Hydrochloride — NDC 10702-0010-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10702001001.

Free to cite with attribution — see how the data is put together.